Literature DB >> 18598943

In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.

Christoph le Viseur1, Marc Hotfilder, Simon Bomken, Kerrie Wilson, Silja Röttgers, André Schrauder, Annegret Rosemann, Julie Irving, Ronald W Stam, Leonard D Shultz, Jochen Harbott, Heribert Jürgens, Martin Schrappe, Rob Pieters, Josef Vormoor.   

Abstract

We examined the leukemic stem cell potential of blasts at different stages of maturation in childhood acute lymphoblastic leukemia (ALL). Human leukemic bone marrow was transplanted intrafemorally into NOD/scid mice. Cells sorted using the B precursor differentiation markers CD19, CD20, and CD34 were isolated from patient samples and engrafted mice before serial transplantation into primary or subsequent (up to quaternary) recipients. Surprisingly, blasts representative of all of the different maturational stages were able to reconstitute and reestablish the complete leukemic phenotype in vivo. Sorted blast populations mirrored normal B precursor cells with transcription of a number of stage-appropriate genes. These observations inform a model for leukemia-propagating stem cells in childhood ALL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598943      PMCID: PMC2572185          DOI: 10.1016/j.ccr.2008.05.015

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  38 in total

1.  Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children.

Authors:  Jeroen G Noordzij; Sandra de Bruin-Versteeg; W Marieke Comans-Bitter; Nico G Hartwig; Rudolf W Hendriks; Ronald de Groot; Jacques J M van Dongen
Journal:  Pediatr Res       Date:  2002-02       Impact factor: 3.756

2.  A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia.

Authors:  C Cobaleda; N Gutiérrez-Cianca; J Pérez-Losada; T Flores; R García-Sanz; M González; I Sánchez-García
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

Review 3.  Acute lymphoblastic leukemia in children.

Authors:  C H Pui
Journal:  Curr Opin Oncol       Date:  2000-01       Impact factor: 3.645

4.  Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment.

Authors:  P B van Hennik; A E de Koning; R E Ploemacher
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

Review 5.  Clonal diversity of Ig and T-cell receptor gene rearrangements in childhood B-precursor acute lymphoblastic leukaemia.

Authors:  T Stankovic; V Weston; C M McConville; E Green; J E Powell; J R Mann; P J Darbyshire; A M Taylor
Journal:  Leuk Lymphoma       Date:  2000-01

6.  Investigation of clonal involvement of myeloid cells in Philadelphia-positive and high hyperdiploid acute lymphoblastic leukemia.

Authors:  A Kasprzyk; C J Harrison; L M Secker-Walker
Journal:  Leukemia       Date:  1999-12       Impact factor: 11.528

7.  Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.

Authors:  Dengli Hong; Rajeev Gupta; Philip Ancliff; Ann Atzberger; John Brown; Shamit Soneji; Joanne Green; Sue Colman; Wanda Piacibello; Veronica Buckle; Shinobu Tsuzuki; Mel Greaves; Tariq Enver
Journal:  Science       Date:  2008-01-18       Impact factor: 47.728

8.  Comment on "Tumor growth need not be driven by rare cancer stem cells".

Authors:  James A Kennedy; Frédéric Barabé; Armando G Poeppl; Jean C Y Wang; John E Dick
Journal:  Science       Date:  2007-12-14       Impact factor: 47.728

9.  Characterization of early stages of human B cell development by gene expression profiling.

Authors:  Marit E Hystad; June H Myklebust; Trond H Bø; Einar A Sivertsen; Edith Rian; Lise Forfang; Else Munthe; Andreas Rosenwald; Michael Chiorazzi; Inge Jonassen; Louis M Staudt; Erlend B Smeland
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

10.  Tumor growth need not be driven by rare cancer stem cells.

Authors:  Priscilla N Kelly; Aleksandar Dakic; Jerry M Adams; Stephen L Nutt; Andreas Strasser
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

View more
  97 in total

Review 1.  Update on developmental therapeutics for acute lymphoblastic leukemia.

Authors:  Malcolm A Smith
Journal:  Curr Hematol Malig Rep       Date:  2009-07       Impact factor: 3.952

2.  Immature B-cell progenitors survive oncogenic stress and efficiently initiate Ph+ B-acute lymphoblastic leukemia.

Authors:  Robert A J Signer; Encarnacion Montecino-Rodriguez; Owen N Witte; Kenneth Dorshkind
Journal:  Blood       Date:  2010-06-18       Impact factor: 22.113

Review 3.  Cancer stem cells: a new framework for the design of tumor therapies.

Authors:  Boyan K Garvalov; Till Acker
Journal:  J Mol Med (Berl)       Date:  2010-10-02       Impact factor: 4.599

4.  Modelling acute leukemias in mice: clonal evolution and the emergence of leukemic stem cells.

Authors:  Bastien Gerby; Trang Hoang
Journal:  BMC Proc       Date:  2013-04-04

5.  Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.

Authors:  Xueliang Wang; Yunjiang Liu; Kaixuan Zhou; Geng Zhang; Feifei Wang; Jingwen Ren
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

6.  Cancer stem cells are enriched in the side population cells in a mouse model of glioma.

Authors:  Molly A Harris; Hyuna Yang; Benjamin E Low; Joydeep Mukherjee; Joydeep Mukherje; Abhijit Guha; Roderick T Bronson; Leonard D Shultz; Mark A Israel; Kyuson Yun
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia.

Authors:  Kerrie Wilson; Marian Case; Lynne Minto; Simon Bailey; Nick Bown; Jenny Jesson; Sarah Lawson; Josef Vormoor; Julie Irving
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

Review 8.  Role of Pericellular Matrix in the Regulation of Cancer Stemness.

Authors:  Sofia Avnet; Margherita Cortini
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

9.  Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Authors:  Stephan A Grupp; Michael Kalos; David Barrett; Richard Aplenc; David L Porter; Susan R Rheingold; David T Teachey; Anne Chew; Bernd Hauck; J Fraser Wright; Michael C Milone; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2013-03-25       Impact factor: 91.245

Review 10.  Understanding the cancer stem cell.

Authors:  S Bomken; K Fiser; O Heidenreich; J Vormoor
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.